Acadia Healthcare price target raised to $105 from $100 at BofA

BofA raised the firm’s price target on Acadia Healthcare to $105 from $100 and keeps a Buy rating on the shares. The firm is raising its EBITDA estimates following the quarter and rolling out 2026 estimates. Acadia guided to 2024 revenue and adjusted EBITDA that is “essentially in-line with consensus when excluding a one time state payment,” though adjusted EPS guidance was 7% below consensus on higher interest expense, the analyst noted.